HaoYuan Chemexpress Files for IPO on the Star Market
Shanghai HaoYuan Chemexpress applied for a public listing on China’s Star Market and will attend the review meeting on November 9. It is a biotechnology company that focuses on developing small-molecular medicines and provides research and manufacturing services. The company plans to raise CNY 650 million to construct the research center in Shanghai and Anhui and produce active ingredients (AI) for 121.095 tons and liquidity.
This text is a result of machine translation.
Briefing Jan 08, 2021 11:30 AM
· Healthcare
Xinyi biological completed 150 million round B financing, and Lilly Asia Fund led investment in Huachuang capital, hillhood venture capital and other follow-up investment
Briefing Dec 30, 2020 05:28 PM
· Healthcare
Another protein component special medical food was approved, and the total number of approved products increased to 57
In depth
Healthcare
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
Briefing Dec 28, 2020 02:44 PM
· Healthcare
BGI and Hanwei intelligent medical jointly launched mobile "two cancer" intelligent screening
Briefing Dec 02, 2020 11:21 AM
· Healthcare
Improving service quality and enabling industrial innovation!
Research
Consumer Staples, Healthcare, TechnologyWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Dec 09, 2020 08:55 AM
Research
Industrials, Financials, AutomotiveTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Briefing Nov 17, 2020 08:04 PM
· Healthcare
Plan to raise $4 billion! Jingdong health runs IPO
Briefing Nov 11, 2020 10:42 AM
· Healthcare
Drug Innovator Asieris Nabs CNY 700 Million Series D
Briefing Oct 16, 2020 04:24 PM
· Healthcare
Beijing Immunochina Pharmaceutical Closes Series C+ at CNY 100 Mn
Briefing Sep 28, 2020 08:25 PM
· Healthcare
Chinese Biotech Zai Laboratory Lands on HKEX after 3 Years' Listing on Nasdaq
Healthcare
WIM2020: Insights on the Post-pandemic Outlook for the Healthcare Industry
The curtain came down on Dec 10 on the 'Healthtech Industry and COVID-19 Pandemic' Chapter at WIM 2020. Healthtech entrepreneurs and investors gathered to share insights on the outlook for the healthcare industry, covering topics like vaccination, AI healthcare, intelligent hardware, medical appliances and IVD.
Jan 07, 2021 02:10 PM
Healthcare, Automotive, Real Estate
WIM2020: Uniting the World through Technology and Innovation
On December 9-12, EqualOcean held the World Innovators Meet (WIM) 2020. This year, the event's main topic was 'Technology and Innovation Connect the World.' WIM2020 gathered innovators from Asia, Africa, Europe and North America to share their knowledge and key achievements, promoting the concept of 'Tech for Equal.'
Dec 17, 2020 07:53 PM
Briefing Sep 28, 2020 12:12 PM
· Healthcare
AI-Based Drug Research Platform XtalPi Closes Series C at USD 318.8 Mn
Briefing Sep 28, 2020 10:49 AM
· Healthcare
Broncus Biotech Closes Series C of Multi-Tens Millions US Dollars
Briefing Sep 23, 2020 11:37 AM
· Healthcare
Top-Tier CDMO Heyuan China Closes Series C at over CNY 300 Mn
Healthcare
EqualOcean Presents Next 50 in Global Tech: Healthcare (WIA2020)
On December 9-12, EqualOcean is holding the World Innovators Meet (WIM) 2020. This year, the event's main topic is 'Technology and Innovation Connect the World.' WIM2020 gathers innovators from Asia, Africa, Europe and the Americas to share their knowledge and key achievements, promoting the concept of 'Tech for Equal.'
Dec 11, 2020 07:35 PM
Briefing Sep 23, 2020 11:11 AM
· Healthcare
Tongshu Gene Closes Series B of Multi-Hundreds Millions
Briefing Sep 18, 2020 10:58 AM
· Healthcare
Biotech IMAB’s In-Process New Drug Enters Clinical Trials
Briefing Sep 15, 2020 12:24 PM
· Healthcare
Antibody Developer Biocytogen Closes Series D+ at CNY 790 Mn
Briefing Sep 14, 2020 06:28 PM
· Healthcare
Nasdaq-listed Biotech ZLAB Passes the Hearing for Hong Kong IPO
See more
Read next
Industrials · Analysis
'New Infrastructure' Enhances TGOOD's Development Potential
Jan 14, 2021 03:19 PM
In depth
Financials
China Life Insurance: What's Going On with the Former Industry Champion?
Jan 14, 2021 10:53 AM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.